Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Falk G Bechara

Showing results (121-130 of 132) with videos related to

Pageof 14
Sort By:
Experimental Dermatology|September 13, 2017
Proceeding report of the Symposium on Hidradenitis Suppurativa Advances (SHSA)Ali Mehdizadeh, Afsaneh Alavi, Raed Alhusayen, et al.
Lancet (London, England)|February 6, 2023
Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trialsAlexa B Kimball, Gregor B E Jemec, Afsaneh Alavi, et al.
Journal of the American Academy of Dermatology|August 27, 2025
Establishment of standardized definitions and a core set of outcome characteristics following hidradenitis suppurativa surgery developed by an expert Delphi consensusLinnea L Westerkam, Hessel H van der Zee, Falk G Bechara, et al.
The Journal of Investigative Dermatology|June 20, 2024
Standardized Protocols for Clinical and Histopathological Characterization of Hidradenitis Suppurativa Tissue SpecimensAshwath Jonathan Sampath, Linnea L Westerkam, Franklin R Blum, et al.
The British Journal of Surgery|May 3, 2023
European e-Delphi process to define expert consensus on electrochemotherapy treatment indications, procedural aspects, and quality indicators in melanomaLuca G Campana, Sofia Farronato, Jackie Hodgetts, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 13, 2025
Towards the development of upgrade criteria for the treatment of hidradenitis suppurativa with biologicsGeorgios Nikolakis, Erkan Alpsoy, Monika Arenbergerova, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 16, 2023
S3 guideline "actinic keratosis and cutaneous squamous cell carcinoma" - update 2023, part 2: epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and preventionUlrike Leiter, Markus V Heppt, Theresa Steeb, et al.
Journal of the American Academy of Dermatology|July 7, 2019
Evaluating patients' unmet needs in hidradenitis suppurativa: Results from the Global Survey Of Impact and Healthcare Needs (VOICE) ProjectAmit Garg, Erica Neuren, Denny Cha, et al.
JAMA Dermatology|September 27, 2023
Outcome Measures for the Evaluation of Treatment Response in Hidradenitis Suppurativa for Clinical Practice: A HiSTORIC Consensus StatementNicole Mastacouris, Rachel Tannenbaum, Andrew Strunk, et al.
The British Journal of Dermatology|September 3, 2022
Factors associated with treatment satisfaction in patients with hidradenitis suppurativa: results from the Global VOICE projectBria Midgette, Andrew Strunk, Oleg Akilov, et al.
Pageof 14

Showing results (121-130 of 132) with videos related to

Sort By:
Pageof 14
Experimental Dermatology|September 13, 2017
Proceeding report of the Symposium on Hidradenitis Suppurativa Advances (SHSA)Ali Mehdizadeh, Afsaneh Alavi, Raed Alhusayen, et al.
Lancet (London, England)|February 6, 2023
Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trialsAlexa B Kimball, Gregor B E Jemec, Afsaneh Alavi, et al.
Journal of the American Academy of Dermatology|August 27, 2025
Establishment of standardized definitions and a core set of outcome characteristics following hidradenitis suppurativa surgery developed by an expert Delphi consensusLinnea L Westerkam, Hessel H van der Zee, Falk G Bechara, et al.
The Journal of Investigative Dermatology|June 20, 2024
Standardized Protocols for Clinical and Histopathological Characterization of Hidradenitis Suppurativa Tissue SpecimensAshwath Jonathan Sampath, Linnea L Westerkam, Franklin R Blum, et al.
The British Journal of Surgery|May 3, 2023
European e-Delphi process to define expert consensus on electrochemotherapy treatment indications, procedural aspects, and quality indicators in melanomaLuca G Campana, Sofia Farronato, Jackie Hodgetts, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 13, 2025
Towards the development of upgrade criteria for the treatment of hidradenitis suppurativa with biologicsGeorgios Nikolakis, Erkan Alpsoy, Monika Arenbergerova, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 16, 2023
S3 guideline "actinic keratosis and cutaneous squamous cell carcinoma" - update 2023, part 2: epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and preventionUlrike Leiter, Markus V Heppt, Theresa Steeb, et al.
Journal of the American Academy of Dermatology|July 7, 2019
Evaluating patients' unmet needs in hidradenitis suppurativa: Results from the Global Survey Of Impact and Healthcare Needs (VOICE) ProjectAmit Garg, Erica Neuren, Denny Cha, et al.
JAMA Dermatology|September 27, 2023
Outcome Measures for the Evaluation of Treatment Response in Hidradenitis Suppurativa for Clinical Practice: A HiSTORIC Consensus StatementNicole Mastacouris, Rachel Tannenbaum, Andrew Strunk, et al.
The British Journal of Dermatology|September 3, 2022
Factors associated with treatment satisfaction in patients with hidradenitis suppurativa: results from the Global VOICE projectBria Midgette, Andrew Strunk, Oleg Akilov, et al.
Pageof 14